Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) FCF Margin (2024 - 2025)

Camp4 Therapeutics (CAMP) has disclosed FCF Margin for 2 consecutive years, with 1795.11% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 349910.0% to 1795.11% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 852.83% through Dec 2025, up 613521.0% year-over-year, with the annual reading at 852.83% for FY2025, 613521.0% up from the prior year.
  • FCF Margin hit 1795.11% in Q4 2025 for Camp4 Therapeutics, up from 1408.81% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 1795.11% in Q4 2025 to a low of 1703.99% in Q4 2024.